Cargando…
Identification of Candidate Biomarker and Drug Targets for Improving Endometrial Cancer Racial Disparities
Racial disparities in incidence and survival exist for many human cancers. Racial disparities are undoubtedly multifactorial and due in part to differences in socioeconomic factors, access to care, and comorbidities. Within the U.S., fundamental causes of health inequalities, including socio-economi...
Autores principales: | Javadian, Pouya, Xu, Chao, Sjoelund, Virginie, Borden, Lindsay E., Garland, Justin, Benbrook, Doris Mangiaracina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318530/ https://www.ncbi.nlm.nih.gov/pubmed/35887124 http://dx.doi.org/10.3390/ijms23147779 |
Ejemplares similares
-
Histopathologic, Genetic and Molecular Characterization of Endometrial Cancer Racial Disparity
por: Javadian, Pouya, et al.
Publicado: (2021) -
Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets
por: Rai, Rajani, et al.
Publicado: (2021) -
Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer
por: Rai, Rajani, et al.
Publicado: (2020) -
Utility and Mechanism of SHetA2 and Paclitaxel for Treatment of Endometrial Cancer
por: Chandra, Vishal, et al.
Publicado: (2021) -
Therapeutic options for management of endometrial hyperplasia
por: Chandra, Vishal, et al.
Publicado: (2016)